![]() |
Page History
...
Agenda of May 3, 2021 meeting
Topic |
---|
Establishing next generation dynamic susceptibility contrast MRI based biomarkers for neuro-oncologic applications Dr. Chad Quarles, PhD Dynamic susceptibility contrast (DSC) MRI is one of the most widely used physiologic imaging techniques in neuro-oncology, enabling the differentiation of glioma grades, identification of tumor components in non-enhancing glioma, reliable detection of recurrence, and early detection of therapy response. This presentation will highlight how an improved understanding of the biophysics of the contrast mechanisms underlying DSC-MRI enabled the recent standardization of acquisition protocols for multi-site clinical trials, is leading to the field’s first benchmark for software validation, and is informing the development of advanced pulse sequences and analysis strategies tailored to specific clinical challenges faced in the management of brain cancer patients. TBD |
|
|
...